• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Apria Inc.

    3/29/22 8:55:14 AM ET
    $APR
    Medical/Dental Instruments
    Health Care
    Get the next $APR alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 333-252146
    Issuer: Apria, Inc.
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 26220 Enterprise Court
    Lake Forest CALIFORNIA 92630
    Telephone number: 9,496,392,018
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Common stock
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2022-03-29 By Tara Petta AVP
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $APR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $APR

    DatePrice TargetRatingAnalyst
    1/11/2022$37.50Buy → Neutral
    UBS
    1/10/2022$39.00Buy
    Citigroup
    11/19/2021$39.00Buy
    Citigroup
    11/8/2021$43.00Buy
    Citigroup
    7/19/2021$32.00 → $29.00Buy → Neutral
    Goldman Sachs
    6/30/2021$33.00Buy
    Citigroup
    More analyst ratings

    $APR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Apria Announces Financial Results for Fourth Quarter and Full Year 2021

      INDIANAPOLIS, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the fourth quarter and full year ended December 31, 2021. As previously announced, the Company will not be hosting a conference call to discuss its financial results. "We reported solid fourth quarter financial results and 2021 was a good year for Apria. Our team did an excellent job operating and executing at a high level while navigating the challenges from the COVID-19 pandemic, as well as a major product recall and supply chain constraints. Fourth

      2/28/22 6:30:00 AM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • Apria Announces Expiration of Hart-Scott-Rodino Waiting Period

      INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its previously announced transaction with Owens & Minor, Inc. The closing of the transaction remains subject to approval by holders of a majority of the Company's outstanding common stock and other customary closing conditions. About Apria Apria is a leading provider of integrated home healthcare equipment and related services in the United States,

      2/24/22 4:05:00 PM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

      Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

      1/10/22 6:00:00 AM ET
      $APR
      $OMI
      Medical/Dental Instruments
      Health Care
      Medical Specialities

    $APR
    Leadership Updates

    Live Leadership Updates

    See more
    • Apria Appoints Christopher G. Lee as Chief Accounting Officer

      INDIANAPOLIS, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today the appointment of Christopher G. Lee as Chief Accounting Officer, a newly created position. Mr. Lee will report to Debra Morris, Apria's Chief Financial Officer. Mr. Lee has 18 years of accounting and financial leadership experience. He joined Apria in February 2009 and has risen internally to his most recent role as Senior Vice President, Accounting and Finance. Prior to joining Apria, Mr. Lee was with Deloitte & Touche. Mr. Lee is a graduate of the University of California a

      10/4/21 8:00:00 AM ET
      $APR
      Medical/Dental Instruments
      Health Care

    $APR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Walker Robert P. returned $192,450 worth of shares to the company (5,132 units at $37.50), closing all direct ownership in the company (tax liability)

      4 - Apria, Inc. (0001735803) (Issuer)

      3/29/22 4:31:49 PM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • SEC Form 4: Apria Holdings Llc sold $532,031,812 worth of shares (14,187,515 units at $37.50)

      4 - Apria, Inc. (0001735803) (Issuer)

      3/29/22 4:31:15 PM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Snyder Lynn Shapiro to satisfy withholding obligation

      4 - Apria, Inc. (0001735803) (Issuer)

      3/29/22 4:31:20 PM ET
      $APR
      Medical/Dental Instruments
      Health Care

    $APR
    SEC Filings

    See more
    • SEC Form 15-12B filed by Apria Inc.

      15-12B - Apria, Inc. (0001735803) (Filer)

      4/8/22 10:10:58 AM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • SEC Form 25-NSE filed by Apria Inc.

      25-NSE - Apria, Inc. (0001735803) (Subject)

      3/29/22 8:55:14 AM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • SEC Form S-8 POS filed by Apria Inc.

      S-8 POS - Apria, Inc. (0001735803) (Filer)

      3/29/22 8:35:01 AM ET
      $APR
      Medical/Dental Instruments
      Health Care

    $APR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Apria downgraded by UBS with a new price target

      UBS downgraded Apria from Buy to Neutral and set a new price target of $37.50

      1/11/22 6:43:54 AM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • Citigroup resumed coverage on Apria with a new price target

      Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

      1/10/22 7:15:48 AM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • Citigroup resumed coverage on Apria with a new price target

      Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

      11/19/21 7:12:27 AM ET
      $APR
      Medical/Dental Instruments
      Health Care

    $APR
    Financials

    Live finance-specific insights

    See more
    • Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

      Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

      1/10/22 6:00:00 AM ET
      $APR
      $OMI
      Medical/Dental Instruments
      Health Care
      Medical Specialities
    • Apria to Announce Third Quarter 2021 Financial Results

      INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal third quarter 2021 financial results on Thursday, November 4, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID 4161279; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listeni

      10/21/21 8:00:00 AM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • Apria to Announce Second Quarter 2021 Financial Results

      INDIANAPOLIS, July 22, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal second quarter 2021 financial results on Thursday, August 5, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID # 5380517; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listen

      7/22/21 4:05:00 PM ET
      $APR
      Medical/Dental Instruments
      Health Care

    $APR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Apria Inc. (Amendment)

      SC 13G/A - Apria, Inc. (0001735803) (Subject)

      4/8/22 4:04:00 PM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Apria Inc.

      SC 13G - Apria, Inc. (0001735803) (Subject)

      3/10/22 5:01:54 PM ET
      $APR
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Apria Inc.

      SC 13G - Apria, Inc. (0001735803) (Subject)

      2/14/22 4:06:09 PM ET
      $APR
      Medical/Dental Instruments
      Health Care